🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
The goal of this phase 2 clinical trial is to test the efficacy of decitabi...
Status
Recruiting
Location
Seoul National University Bundang Hospital
Start Date
2025-01-30
Trial ID
NCT06712121
Treatments Being Tested
Background: Bruton s tyrosine kinase inhibitors (BTKi) are used to treat a...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2023-03-01
Trial ID
NCT05724121
To assess the safety, tolerability and pharmacokinetics of ABT-199 in femal...
Status
Completed
Location
Site Reference ID/Investigator# 89694
Start Date
2012-11
Trial ID
NCT01686555
This trial will look at a drug called SEA-CD70 with and without azacitidine...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-08-07
Trial ID
NCT04227847
Treatments Being Tested
This is a prospective phase II, single-arm clinical study that plans to enr...
Status
Unknown
Location
The Second Affiliated Hospital of Kunming Medical University.
Start Date
2023-04-01
Trial ID
NCT05949762
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
Acute Myeloid Leukemia (AML) is an aggressive and rare cancer of myeloid ce...
Status
Completed
Location
Pusan National University Hospital /ID# 239010
Start Date
2021-04-05
Trial ID
NCT04826523
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested